Experienced Research Scientist with over 12 years in genetic analysis (Next Generation Sequencing) and plasma biomarkers
(SIMOA and ELISA), specializing in neurological diseases and viral infections. Ph.D. in Parasitic and Molecular Biology with
expertise in Herpesvirus research, CRISPR/Cas9 antiviral strategies, and in vivo RNAi treatments for Herpetic Encephalitis.
Skilled in multiplex qPCR diagnostics and antiviral studies, with a strong background in biosafety, molecular biology, and
gene editing. Highly-motivated employee with desire to take on new challenges. Strong work ethic, adaptability, and
exceptional interpersonal skills. Adept at working effectively unsupervised and quickly mastering new skills.
Overview
13
13
years of professional experience
1
1
Language
Work History
Postdoctoral Researcher
Universidade Federal do Estado do RJ, Rio De Janeiro, Rio De Janeiro
09.2021 - 09.2024
Executed and coordinated research projects in precision medicine for
neurosciences
Identified genetic variants linked to clinical outcomes and radiological
profiles in patients with neurodegenerative and inflammatory
demyelinating diseases (IDD) of the CNS
Conducted exome analysis of Neuromyelitis optica patients
Monitored the entry and collection of biological samples from patients for
research
Biomarker detection (ELISA and SIMOA assays) related to demyelinating
diseases, neuroinflammatory conditions, and viral infections with
neurological manifestations
Managed the genetic sequencing (NGS Illumina) platform and its activities
Trained staff in experiment execution
Supervised undergraduate, master's, and doctoral students.
Participated in conferences and presented research work
Engaged in teaching practices for undergraduate courses.
Doctoral Researcher
Fundação Oswaldo Cruz
Rio De Janeiro, RJ
03.2017 - 09.2021
Analyzed the antiviral activity of CRISPR/Cas9 against HSV-1 in vitro
Supervised undergraduate students
Attended conferences and presented research work in the field
Published the first report of triple Betaherpesvirus infection
Demonstrated that the CRISPR/Cas9 anti-HSV-1 complex effectively
inhibited HSV-1 replication.
Master Research Fellow
FUNDAÇÃO OSWALDO CRUZ, BRAZIL | Rio De Janeiro, RJ
, DE
01.2015 - 01.2017
Developed a multiplex qPCR test for simultaneous detection of three
Betaherpesvirinae viruses, crucial for diagnosing herpesviruses in
transplant patients and autoimmune diseases
Presented research at events, congresses, and field-specific conferences.
Student Researcher
FUNDAÇÃO OSWALDO CRUZ, Rio De, Janeiro, RJ
01.2012 - 01.2014
Infected BALB/c mice with HSV-1 to study viral effects
Assessed and compared HSV-1 viral loads of KOS and EK strains in
BALB/c mice through cell culture (p.f.u)
Demonstrated the use of siRNA in vivo to inhibit HSV-1 replication,
reduce clinical signs of Herpetic Encephalitis (HSE), and increase survival
time in mice.
Education
light chain in mild COVID-19 patients Molecular Psychiatry -
01.2024
DOI:
10.1038/s -
01.2023
DOI: 10.1016/j. -
01.2023
CRISPR/Cas-9 vector system: targets UL-39 and inhibits HSV -
01.2023
High Levels of NfL, GFAP, TAU, and UCH-L1 as Predictor Biomarkers in Acute COVID-19 Molecular Neurobiology -
01.2023
Exome Analysis Course -
Instituto Carlos Chagas - Fiocruz, ICC
01.2022
PhD - Molecular Biology
Fundação Oswaldo Cruz
09.2021
10.1007/s12035-023-03803-z.
Molecular Mimicry between SARS-CoV-2 and CNS Autoimmune Disorders Microorganisms, 2023. DOI -
Residente jurídico at Ministério Público do Estado do Rio de Janeiro (MP/RJ)Residente jurídico at Ministério Público do Estado do Rio de Janeiro (MP/RJ)